Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- amantadine
- Namenda (memantine)
Interactions between your drugs
amantadine memantine
Applies to: amantadine, Namenda (memantine)
Consumer information for this interaction is not currently available.
MONITOR: Coadministration of memantine with other N-methyl-D-aspartate (NMDA) antagonists such as amantadine, ketamine or dextromethorphan may result in additive CNS effects. Data are limited and the clinical significance is unknown.
MANAGEMENT: Caution and clinical monitoring are advised when memantine is coadministered with other N-methyl-D-aspartate (NMDA) antagonists. If coadministration is required, close clinical monitoring for adverse effects (e.g., sedation, psychosis) is advised and dose adjustments may be required, particularly when memantine is initiated or withdrawn from therapy. Individual product labeling should be consulted. Some authorities recommend avoiding the combination of memantine with other NMDA antagonists.
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
NMDA antagonists
Therapeutic duplication
The recommended maximum number of medicines in the 'NMDA antagonists' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'NMDA antagonists' category:
- amantadine
- Namenda (memantine)
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Ingrezza
Ingrezza (valbenazine) is used to treat tardive dyskinesia (TD) and chorea associated with ...
Benadryl
Benadryl is an antihistamine and is used to treat sneezing, runny nose, itching and other ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Tamiflu
Tamiflu is an antiviral medication used to treat flu symptoms caused by influenza. Learn about side ...
Sinemet
Sinemet is used to treat symptoms of Parkinson's disease, such as muscle stiffness, tremors ...
Cogentin
Cogentin is used for extrapyramidal reaction, parkinson's disease
Requip
Requip is used to treat symptoms of Parkinson's disease, such as stiffness, tremors and muscle ...
Austedo
Austedo and Austedo XR are used to treat the involuntary movements of Huntington's disease and ...
Mirapex
Mirapex (pramipexole) treats the symptoms of Parkinson's disease and is also used to treat Restless ...
Vitamin B6
Vitamin B6 is used for anemia, dietary supplementation, drug induced vitamin/mineral deficiency ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.